购物车
0
有库存
HIT211999913
 sdf 文件
结构编辑
类似物检索
HIT211999913
  • HIT ID:HIT211999913
  • Cas No:896126-03-7
  • 常用名:ABO hydrochloride
  • IUPAC:(6-amino-3,4-dihydro-2H-1,4-benzoxazin-3-yl)methanol dihydrochloride
    IUPAC:(6-amino-3,4-dihydro-2H-1,4-benzoxazin-3-yl)methanol dihydrochloride
  • InChI key:WQHCJHKXKVXAEW-UHFFFAOYSA-N
  • 分子式:C9H14Cl2N2O2
  • 分子量:253.12
  • 氢键供体数 (HBD):3
  • 氢键受体数 (HBA):4
  • LogP:-0.34243315
  • SMILES:Cl.Cl.Nc1ccc2OCC(CO)Nc2c1
    SMILES:Cl.Cl.Nc1ccc2OCC(CO)Nc2c1
  • ABO acts as an annexin A7 modulator, specifically binding to Thr286 to inhibit its phosphorylation on threonine (not on serine or tyrosine) residues within human umbilical vein endothelial cells (HUVECs). This compound furthers the annexin A7 interaction with the EF-hand protein GCA, leading to reduced GCA phosphorylation, lowered intracellular calcium levels, and enhanced autophagy in COS-7 cells. Moreover, ABO lessens phosphorylation of the microtubule-associated protein 1 light chain (LC3) in HUVECs and impedes the upregulation of phosphatidylcholine-specific phospholipase C (PC-PLC) due to oxidized low-density lipoprotein in vascular endothelial cells (VECs). In animal models, specifically apoE-/- mice on a Western diet, administration of ABO (50 or 100 mg/kg per day) has been shown to decrease PC-PLC expression, promote autophagy, and reduce apoptosis, lipid accumulation, and the extent of atherosclerotic plaques in the aortic endothelium.
市场产品/服务共显示2个结果
  • 供应商
    TargetMolSC
    规格
    货期
    35日内发货
    纯度
    -
    ¥ 539.00
    1
  • 供应商
    BIONET-Key OrganicsBB
    规格
    货期
    4-6周
    纯度
    -
    待询
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~